Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Current Deferred Revenue (2021 - 2025)

Historic Current Deferred Revenue for Prothena Corp Public (PRTA) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Prothena Corp Public's Current Deferred Revenue fell 6959.92% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 6959.92%. This contributed to the annual value of $8.8 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Prothena Corp Public's Current Deferred Revenue stood at $2.7 million, which was down 6959.92% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Current Deferred Revenue peaked at $67.4 million during Q1 2024, and registered a low of $316000.0 during Q3 2023.
  • Its 5-year average for Current Deferred Revenue is $13.1 million, with a median of $8.8 million in 2022.
  • Per our database at Business Quant, Prothena Corp Public's Current Deferred Revenue tumbled by 9673.05% in 2023 and then soared by 269493.67% in 2024.
  • Quarter analysis of 5 years shows Prothena Corp Public's Current Deferred Revenue stood at $7.7 million in 2021, then skyrocketed by 49.43% to $11.4 million in 2022, then plummeted by 97.24% to $316000.0 in 2023, then skyrocketed by 2700.63% to $8.8 million in 2024, then tumbled by 69.66% to $2.7 million in 2025.
  • Its Current Deferred Revenue was $2.7 million in Q3 2025, compared to $5.1 million in Q2 2025 and $7.9 million in Q1 2025.